Study samples are displayed in preparation for the RV575 research study at the Walter Reed Army Institute of Research Sept. 27, 2022. In October, the Military HIV Research Program will launch the phase 1 study, evaluating varying doses of the Army's novel ALFQ adjuvant in a candidate HIV vaccine to determine the optimal adjuvant dosage level.

---

Size: 8192px × 5464px
Photo credit: © Operation 2022 / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: ctc, hiv, research, study, wrair